LBLee Berger

Lee Berger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lee Berger has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Devastating disease can cause increased breeding effort and success that improves population resilience

    by Laura A. Brannelly, Danielle K. Wallace, Alexander S. Wendt, Quinn Higgs, Siyu Zhang, Marcus A. Hough, Ke Diao, Eleyne Ferguson, Lee Berger, Lee F. Skerratt

    Novel and invasive diseases are a key threat to wildlife. The disease chytridiomycosis has had devastating global impacts, but some amphibian species can persist and even rebound after severe declines. Understanding how these species persist is critical to discovering management techniques for supporting declining species. Here, we explored the impacts of disease on reproduction in the threatened Litoria verreauxii alpina , investigating its effect on reproductive effort and success using a combination of laboratory-based clinical trials and field sampling through capture–mark–recapture surveys. We found that male frogs are increasing various facets of their breeding effort resulting in increased offspring. Infected male frogs (i) increased vocal sac coloration, (ii) increased sperm quality, and (iii) fathered more egg masses than uninfected males. Our research demonstrates that frogs can counteract high disease-caused mortality through enhanced breeding effort, which could lead to population persistence. Mitigation for wildlife diseases often aims to directly reduce mortality, such as through increasing host resistance or decreasing environmental suitability for the pathogen. Our work indicates that reproductive output is also important and should be considered when protecting our precious amphibians.


  • Open Access

    Advances in Managing Chytridiomycosis for Australian Frogs: Gradarius Firmus Victoria

    by Lee Berger, Lee F. Skerratt, Tiffany A. Kosch, Laura A. Brannelly, Rebecca J. Webb, Anthony W. Waddle

    Extensive knowledge gains from research worldwide over the 25 years since the discovery of chytridiomycosis can be used for improved management. Strategies that have saved populations in the short term and/or enabled recovery include captive breeding, translocation into disease refugia, translocation from resistant populations, disease-free exclosures, and preservation of disease refuges with connectivity to previous habitat, while antifungal treatments have reduced mortality rates in the wild. Increasing host resistance is the goal of many strategies under development, including vaccination and targeted genetic interventions. Pathogen-directed strategies may be more challenging but would have broad applicability. While the search for the silver bullet solution continues, we should value targeted local interventions that stop extinction and buy time for evolution of resistance or development of novel solutions. As for most invasive species and infectious diseases, we need to accept that ongoing management is necessary. For species continuing to decline, proactive deployment and assessment of promising interventions are more valid than a hands-off, do-no-harm approach that will likely allow further extinctions.


  • Open Access

    Conserved Evolution of MHC Supertypes among Japanese Frogs Suggests Selection for Bd Resistance

    by Quintin Lau, Takeshi Igawa, Tiffany A. Kosch, Anik B. Dharmayanthi, Lee Berger, Lee F. Skerratt, Yoko Satta

    The chytrid fungus Batrachochytrium dendrobatidis (Bd) is a major threat to amphibians, yet there are no reports of major disease impacts in East Asian frogs. Genetic variation of the major histocompatibility complex (MHC) has been associated with resistance to Bd in frogs from East Asia and worldwide. Using transcriptomic data collated from 11 Japanese frog species (one individual per species), we isolated MHC class I and IIb sequences and validated using molecular cloning. We then compared MHC from Japanese frogs and other species worldwide, with varying Bd susceptibility. Supertyping analysis, which groups MHC alleles based on physicochemical properties of peptide binding sites, identified that all examined East Asian frogs contained at least one MHC-IIb allele belonging to supertype ST-1. This indicates that, despite the large divergence times between some Japanese frogs (up to 145 million years), particular functional properties in the peptide binding sites of MHC-II are conserved among East Asian frogs. Furthermore, preliminary analysis using NetMHCIIpan-4.0, which predicts potential Bd-peptide binding ability, suggests that MHC-IIb ST-1 and ST-2 have higher overall peptide binding ability than other supertypes, irrespective of whether the peptides are derived from Bd, other fungi, or bacteria. Our findings suggest that MHC-IIb among East Asian frogs may have co-evolved under the same selective pressure. Given that Bd originated in this region, it may be a major driver of MHC evolution in East Asian frogs.